Fig. 1.

(A) FP and CO ROI locations from Dosenbach et al. (3) (B) Degree of lesion overlap across all patients. (C) Amount of damage sustained at each node by each subject. Subjects 5–8, despite having lesions elsewhere, sustained no damage to either network.